Resultados de procura - Kate Talks

  • Mostrando 1 - 8 Resultados de 8
Limitar resultados
  1. 1
    Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival

    Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival por Alexandra Giatromanolaki, Michael I. Koukourakis, Efthimios Sivridis, Helen Turley, Kate Talks, Francesco Pezzella, Kevin C. Gatter, Adrian L. Harris

    Publicado 2001
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Guidelines on the use of prophylactic factor replacement for children and adults with Haemophilia A and B

    Guidelines on the use of prophylactic factor replacement for children and adults with Haemophilia A and B por Rachel Rayment, Elizabeth Chalmers, Katherine E. Law, Richard Gooding, Anne M. Kelly, Susan Shapiro, Kate Talks, Oliver Tunstall, Tina Biss

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Diagnosis and management of acquired coagulation inhibitors: a guideline from <scp>UKHCDO</scp>

    Diagnosis and management of acquired coagulation inhibitors: a guideline from <scp>UKHCDO</scp> por Peter W. Collins, Elizabeth Chalmers, Daniel P. Hart, Ian Jennings, Ri Liesner, Savita Rangarajan, Kate Talks, Michael D. Williams, C. R. M. Hay

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Executive Committee

    Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Ex... por Peter W. Collins, Ri Liesner, Michael Makris, Kate Talks, Pratima Chowdary, Elizabeth Chalmers, Georgina Hall, Anne Riddell, Charles Percy, C. R. M. Hay, Daniel P. Hart

    Publicado 2018
    Ligazón do recurso
    Carta
    Engadir a favoritos
    Gardado en:
  5. 5
    Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia

    Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia por Charlotte Bradbury, Julie Pell, Quentin A. Hill, Catherine Bagot, Nichola Cooper, Jenny Ingram, Katie Breheny, Rebecca Kandiyali, Rachel Rayment, Gillian Evans, Kate Talks, Ian Thomas, Rosemary Greenwood

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Induction of Endothelial PAS Domain Protein-1 by Hypoxia: Characterization and Comparison With Hypoxia-Inducible Factor-1α

    Induction of Endothelial PAS Domain Protein-1 by Hypoxia: Characterization and Comparison With Hypoxia-Inducible Factor-1α por Michael S. Wiesener, Helen Turley, William E. Allen, Carsten Willam, Kai‐Uwe Eckardt, Kate Talks, S.M. Wood, Kevin C. Gatter, Adrian L. Harris, Christopher W. Pugh, Peter J. Ratcliffe, Patrick H. Maxwell

    Publicado 1998
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B

    Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B por Pratima Chowdary, Susan Shapiro, Michael Makris, Gillian Evans, Sara Boyce, Kate Talks, Gerard Dolan, Ulrike M. Reiss, Mark Phillips, Anne Riddell, Maria R. Peralta, Michelle Quaye, David Patch, Edward G. D. Tuddenham, Allison Dane, Marie Watissée, Alison Long, Amit C. Nathwani

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Real‐world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the <scp>TRAIT</scp> study

    Real‐world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the <scp>TRAIT</scp> study por Nichola Cooper, Marie Scully, Charles Percy, Phillip L. R. Nicolson, Gillian Lowe, Catherine Bagot, Jecko Thachil, H. Grech, Tim Nokes, Quentin A. Hill, Charlotte Bradbury, Kate Talks, Tina Dutt, Gillian Evans, Sue Pavord, Sarah Wexler, Asad Charania, Sarah J. Collington, Andrew Ervin, Nicholas Ramscar, Drew Provan

    Publicado 2024
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: